BLLN Q2 revenue rises 64% with strong margins and oncology growth
BLLN reported 64% Q2 revenue growth and strong profitability, driven by gains in prenatal and oncology. The company said independent clinics drive most growth, while health system integration investments and new products are set to accelerate expansion.